Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19

The coronavirus disease 2019 (COVID-19) is an unprecedented pandemic that has severely impacted global public health and the economy. Hydroxychloroquine administered orally to COVID-19 patients was ineffective, but its antiviral and anti-inflammatory actions were observed in vitro. The lack of effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Tai, Waiting, Chow, Michael Yee Tak, Chang, Rachel Yoon Kyung, Tang, Patricia, Gonda, Igor, MacArthur, Robert B., Chan, Hak-Kim, Kwok, Philip Chi Lip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399722/
https://www.ncbi.nlm.nih.gov/pubmed/34452220
http://dx.doi.org/10.3390/pharmaceutics13081260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399722/
https://www.ncbi.nlm.nih.gov/pubmed/34452220
http://dx.doi.org/10.3390/pharmaceutics13081260

Ejemplares similares